Pedram Sendi (@PedramSendi) header
Pedram Sendi (@PedramSendi) profile picture

Pedram Sendi

@PedramSendi

Health Economist, Dentist, Physician, Father, Son; Adjunct Professor, Basel University Hospital, Clinical Epidemiology, all views are my own

 Riehen, Schweiz
Joined July 2017
  • Tweets12
  • Following477
  • Followers135
Just out, happy to share with you our recent paper on handling uncertainty in cost-effectiveness analysis with a focus on budget constraints and risk-version, together with Klazien Matter-Walstra and Matthias Schwenkglenks. mdpi.com/2227-9032/9/11/1419
Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion

Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion

Methods to handle uncertainty in economic evaluation have gained much attention in the literature, and the cost-effectiveness acceptability curve (CEAC) is the most widely used method to summarise...

mdpi.com
1
2
Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine mdpi.com/1178410 ##mdpiijerph via @IJERPH_MDPI
Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine

Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine

Background: The number of contingent valuation (CV) studies in dental medicine using willingness-to-pay (WTP) methodology has substantially increased in recent years. Missing values due to absent...

mdpi.com
1
1
Great @CHEyork economic evaluation seminar this week by @PedramSendi - many thanks. Hoping to try out some of the indices discussed in future work around local decision-making with @Franklin86Matt, @danielhowdon, @sebh2005 et al 🤞
Pedram Sendi (@PedramSendi) profile picturePedram Sendi@PedramSendi14 Nov 2020
cost-effectiveness analysis under risk-aversion, some thoghts how we could address these issues link.springer.com/article/10…
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

PharmacoEconomics - Cost-effectiveness analysis has been advocated and is widely used to inform policy and decision makers in setting priorities for resource allocation. Since the costs and effects...

link.springer.com
2
3
cost-effectiveness analysis under risk-aversion, some thoghts how we could address these issues link.springer.com/article/10…
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

PharmacoEconomics - Cost-effectiveness analysis has been advocated and is widely used to inform policy and decision makers in setting priorities for resource allocation. Since the costs and effects...

link.springer.com
4
1
10
Happy to share with you the paper that introduces the cost-effectiveness risk-aversion curve. As the COVID crisis has shown us, decision-makers are highly risk-averse towards health outcomes and, ceteris paribus, also towards costs. link.springer.com/article/10…
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

PharmacoEconomics - Cost-effectiveness analysis has been advocated and is widely used to inform policy and decision makers in setting priorities for resource allocation. Since the costs and effects...

link.springer.com
1
Pedram Sendi retweeted
Pedram Sendi (@PedramSendi) profile picture
Pedram Sendi@PedramSendi3 Nov 2020
Check out the recent paper on handling uncertainty in cost-effectiveness analysis under risk-aversion published in PharmacoEconomics. #HEOR #healthcare #HTA. link.springer.com/article/10…
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

PharmacoEconomics - Cost-effectiveness analysis has been advocated and is widely used to inform policy and decision makers in setting priorities for resource allocation. Since the costs and effects...

link.springer.com
2
1
6
Check out the recent paper on handling uncertainty in cost-effectiveness analysis under risk-aversion published in PharmacoEconomics. #HEOR #healthcare #HTA. link.springer.com/article/10…
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

PharmacoEconomics - Cost-effectiveness analysis has been advocated and is widely used to inform policy and decision makers in setting priorities for resource allocation. Since the costs and effects...

link.springer.com
2
1
6
great contribution, congrats James!
James Lomas (@JamesLomas88) profile pictureJames Lomas@JamesLomas883 Nov 2020
Absolutely brilliant experience working on this important paper with @djvanness and @hannah__Ahn. Please check out the freely available video abstract online and the editorial (also with free video abstract) by @icer_review 's Steve Pearson.
1
Load more